New Vaccine Strategy Increases Number of Tumor-Specific CancerKilling T Cells
| dc.contributor.author | Khalif, Nada O. | |
| dc.date.accessioned | 2019-02-27T09:15:06Z | |
| dc.date.available | 2019-02-27T09:15:06Z | |
| dc.date.issued | 2018-05-05 | |
| dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/541 | |
| dc.description | Current comprehensive cancer care is centered on reducing the bulk of disease through surgery, chemotherapy, and radiation. despite the increasing effectiveness of these cornerstones of treatment and high cure rates of multiple cancer forms, cancer remains a leading cause of death. recent over the past two decades, the emergence of treatments targeting genomic alterations has led to the concept of “personalized” medicine. one good example is the use of small-molecule inhibitors targeting mutations, an approach that has been shown to help shrink tumours, so tumor vaccines have several potential advantages over standard anticancer regiments. they represent highly specific anticancer therapy. | en_US |
| dc.description.abstract | After many years of disappointing results, the tide has finally changed and immunotherapy has become a clinically validated treatment for many cancers. immunotherapeutic strategies include cancer vaccines, so tumor vaccines have several potential advantages over standard anticancer regiments. the purpose of cancer vaccines is to stimulate the body's defenses against cancer by increasing the response of the immune system. mutations and no longer function properly. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.title | New Vaccine Strategy Increases Number of Tumor-Specific CancerKilling T Cells | en_US |
| dc.type | Other | en_US |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution 3.0 United States